Your browser doesn't support javascript.
loading
Exploration of piperidine 3D fragment chemical space: synthesis and 3D shape analysis of fragments derived from 20 regio- and diastereoisomers of methyl substituted pipecolinates.
Jones, S Paul; Firth, James D; Wheldon, Mary C; Atobe, Masakazu; Hubbard, Roderick E; Blakemore, David C; De Fusco, Claudia; Lucas, Simon C C; Roughley, Stephen D; Vidler, Lewis R; Whatton, Maria Ann; Woolford, Alison J-A; Wrigley, Gail L; O'Brien, Peter.
Afiliação
  • Jones SP; Department of Chemistry, University of York Heslington York YO10 5DD UK peter.obrien@york.ac.uk.
  • Firth JD; Department of Chemistry, University of York Heslington York YO10 5DD UK peter.obrien@york.ac.uk.
  • Wheldon MC; Department of Chemistry, University of York Heslington York YO10 5DD UK peter.obrien@york.ac.uk.
  • Atobe M; Department of Chemistry, University of York Heslington York YO10 5DD UK peter.obrien@york.ac.uk.
  • Hubbard RE; Asahi Kasei Pharma Corporation 632-1 Mifuku, Izunokuni Shizuoka 410-2321 Japan.
  • Blakemore DC; Department of Chemistry, University of York Heslington York YO10 5DD UK peter.obrien@york.ac.uk.
  • De Fusco C; Vernalis (R&D) Ltd. Granta Park, Abington Cambridge CB21 6GB UK.
  • Lucas SCC; Medicine Design, Pfizer Inc. 445 Eastern Point Road Groton CT 06340 USA.
  • Roughley SD; Bayer AG, Research and Development, Pharmaceuticals, Synthetic Modalities 13353 Berlin Germany.
  • Vidler LR; Hit Discovery, Discovery Sciences, R&D, AstraZeneca Cambridge CB4 0WG UK.
  • Whatton MA; Vernalis (R&D) Ltd. Granta Park, Abington Cambridge CB21 6GB UK.
  • Woolford AJ; Amphista Therapeutics The Cori Building, Granta Park, Great Abington Cambridge CB21 6GQ UK.
  • Wrigley GL; Evotec (UK) Ltd Dorothy Crowfoot Hodgkin Campus, 114 Innovation Drive, Milton Park, Abingdon Oxon OX14 4RZ UK.
  • O'Brien P; Astex Pharmaceuticals 436 Cambridge Science Park, Milton Road Cambridge CB4 0QA UK.
RSC Med Chem ; 13(12): 1614-1620, 2022 Dec 14.
Article em En | MEDLINE | ID: mdl-36545433
ABSTRACT
Fragment-based drug discovery is now widely adopted for lead generation in the pharmaceutical industry. However, fragment screening collections are often predominantly populated with flat, 2D molecules. Herein, we report the synthesis of piperidine-based 3D fragment building blocks - 20 regio- and diastereoisomers of methyl substituted pipecolinates using simple and general synthetic methods. cis-Piperidines, accessed through a pyridine hydrogenation were transformed into their trans-diastereoisomers using conformational control and unified reaction conditions. Additionally, diastereoselective lithiation/trapping was utilised to access trans-piperidines. Analysis of a virtual library of fragments derived from the 20 cis- and trans-disubstituted piperidines showed that it consisted of 3D molecules with suitable molecular properties to be used in fragment-based drug discovery programs.

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: RSC Med Chem Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: RSC Med Chem Ano de publicação: 2022 Tipo de documento: Article